| Title | Author(s) | Year | View Count |
 | Effects of Azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCTa randomized double-blinded placebo-controlled study | Lam, DCL; Lam, B; Wong, MKY; Lu, C; Au, WY; Tse, EWC; Leung, AYH; Kwong, YL; Liang, RHS; Lam, WK; Ip, MSM; Lie, AKW | 2011 | 889 |
 | Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer | Wong, MKY; Lo, AI; Lam, WK; Lam, B; Ip, MSM; Ho, JCM | 2009 | 157 |
| Alterations of systemic antioxidants and 8-isoprostane during chemotherapy for lung cancer | Ho, JCM; Ho, SP; Mak, JCW; Wong, MKY; Ip, MSM; Lam, WK | 2009 | 124 |
| Diseases of the pleura | Wong, MKY; Ho, JCM | 2007 | 91 |
| Respiratory investigations | Wong, MKY; Pang, CBY; Ho, JCM | 2007 | 96 |
| Interstitial and occupational lung diseases | Wong, MKY; Ho, JCM; Chan, MMW | 2007 | 101 |
| The combined use of gemcitabine and ifosfamide in patients with Stage III or IV non-small cell lung cancer (NSCLC) | Lam, CL; Lam, WK; Ip, MSM; Tsang, KWT; Lam, B; Yan, CPK; Ho, JCM; Ip, S; Wong, MKY | 2002 | 186 |
|
